Abstract
Objective
Cardiac magnetic resonance (CMR) is an uncontested diagnostic tool for identifying and assessing hypertrophic cardiomyopathy (HCM) patients. Concerning the necessity to identify valid prognosticators for predicting the individual risk of clinical evolution, this study aimed to evaluate the clinical validity of CMR tissue tracking (TT) analysis in patients affected by primitive HCM in a real-world setting.
Methods
This historical prospective study included 33 patients. Diagnostic validity and clinical validation were assessed for strain values. CMR-TT diagnostic validity was studied comparing HCM patients with healthy control groups and phenotypic presentation of HCM. The impact of strain values and all phenotypic disease characteristics were assessed in a long-term follow-up study.
Results
The inter-reading agreement was good for all strain parameters. Significant differences were observed between the control group and HCM patients. Similarly, hypertrophic and LGE + segments showed lower deformability than healthy segments. The AUC of predictive model, including conventional risk factors for MACE occurrence and all strain values, reached 98% of diagnostic concordance (95% CI .94–1; standard error: .02; p value .0001), compared to conventional risk factors only (86%; 95% CI .73–99; standard error: .07; p value .002).
Conclusion
In patients with primitive HCM, CMR-TT strain proves high clinical validity providing independent and non-negligible prognostic advantages over clinical features and traditional CMR markers.
Similar content being viewed by others
Abbreviations
- HCM:
-
Hypertrophic cardiomyopathy
- SCD:
-
Sudden cardiac death
- NYHA:
-
New York Heart Association
- LVOTO:
-
Left ventricular outflow tract obstruction
- LGE:
-
Late gadolinium enhancement
- GLS:
-
Global longitudinal strain
- LV:
-
Left ventricular
- CMR:
-
Cardiac magnetic resonance
- ESC:
-
European society of cardiology
- TT:
-
Tissue tracking
- MDE:
-
Myocardial delayed enhancement
- ICD:
-
Implantable cardiac defibrillator
- ICC:
-
Intraclass correlation
- ANOVA:
-
Analysis of variance
- SAM:
-
Systolic anterior motion
- MACE:
-
Major adverse cardiac event
- EF:
-
Ejection fraction
- GRS:
-
Global radial strain
- GCS:
-
Global circumferential strain
- h:
-
Healthy
- HR:
-
Hazard ratio
- AI:
-
Artificial intelligence
References
Maron BJ, Maron MS (2013) Hypertrophic cardiomyopathy. Lancet 381(9862):242–255
Maron BJ (2018) Clinical course and management of hypertrophic cardiomyopathy. N Engl J Med 379(7):655–668
Maron MS, Wells S (2019) Myocardial strain in hypertrophic cardiomyopathy. J Am Coll Cardiol Cardiovasc Imaging 12(10):1943–1945
Liu Q, Li D, Berger AE, Johns RA, Gao L (2017) Survival and prognostic factors in hypertrophic cardiomyopathy: a meta-analysis. Sci Rep 7(1):1–10
Marrakchi S, Kammoun I, Bennour E, Laroussi L, Kachboura S (2020) Risk stratification in hypertrophic cardiomyopathy. Herz 45:50–64
Makavos G, Κairis C, Tselegkidi ME, Karamitsos T, Rigopoulos AG, Noutsias M et al (2019) Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis, and treatment. Heart Fail Rev 24:439–459
Pradella S, Grazzini G, De Amicis C, Letteriello M, Acquafresca M, Miele V (2020) Cardiac magnetic resonance in hypertrophic and dilated cardiomyopathies. Radiol Med 125(11):1056–1071
Ciancarella P, Ciliberti P, Santangelo TP, Secchi F, Stagnaro N, Secinaro A (2020) Noninvasive imaging of congenital cardiovascular defects. Radiol Med 125(11):1167–1185
Esposito A, Gallone G, Palmisano A, Marchitelli L, Catapano F, Francone M (2020) The current landscape of imaging recommendations in cardiovascular clinical guidelines: toward an imaging-guided precision medicine. Radiol Med 125(11):1013–1023
Russo V, Lovato L, Ligabue G (2020) Cardiac MRI: technical basis. Radiol Med 125:1040–1055
Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P et al (2014) 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35(39):2733–2779
Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al (2011) ACCF/AHA Guideline 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, pp 783–831
Briasoulis A, Mallikethi-Reddy S, Palla M, Alesh I, Afonso L (2015) Myocardial fibrosis on cardiac magnetic resonance and cardiac outcomes in hypertrophic cardiomyopathy: a meta-analysis. Heart 101(17):1406–1411
Weng Z, Yao J, Chan RH, He J, Yang X, Zhou Y et al (2016) Prognostic value of LGE-CMR in HCM: a meta-analysis. JACC Cardiovasc Imaging 9(12):1392–1402
Ommen S, Mital S, Burke M, Day SM, Deswal A, Evanovich LL et al (2020) AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2020:e1-82
Satriano A, Heydari B, Guron N, Fenwick K, Cheung M, Mikami Y et al (2019) 3-Dimensional regional and global strain abnormalities in hypertrophic cardiomyopathy. Int J Cardiovasc Imaging 35(10):1913–1924
Inciardi RM, Galderisi M, Nistri S, Santoro C, Cicoira M, Rossi A (2018) Echocardiographic advances in hypertrophic cardiomyopathy: Three-dimensional and strain imaging echocardiography. Echocardiography 35(5):716–726
Palumbo P, Rolf S, Manuel BP, Davide C, Dresselaers T, Claus P et al (2020) Left ventricular global myocardial strain assessment: are CMR feature-tracking algorithms useful in the clinical setting? Radiol Med 125(5):444–450
Vigneault DM, Yang E, Jensen PJ, Tee MW, Farhad H, Chu L et al (2019) Left ventricular strain is abnormal in preclinical and overt hypertrophic cardiomyopathy: cardiac MR feature tracking. Radiology 290(3):640–648
Neisius U, Myerson L, Fahmy AS, Nakamori S, El-Rewaidy H, Joshi G et al (2019) Cardiovascular magnetic resonance feature tracking strain analysis for discrimination between hypertensive heart disease and hypertrophic cardiomyopathy. PLoS ONE 14(8):1–18
Jung HN, Kim SM, Lee JH, Kim Y, Lee SC, Jeon ES et al (2020) Comparison of tissue tracking assessment by cardiovascular magnetic resonance for cardiac amyloidosis and hypertrophic cardiomyopathy. Acta Radiol 61(7):885–893
Sunthankar S, Parra DA, George-Durrett K, Crum K, Chew JD, Christensen J et al (2019) Tissue characterisation and myocardial mechanics using cardiac MRI in children with hypertrophic cardiomyopathy. Cardiol Young 29(12):1459–1467
McComb C, Carrick D, McClure JD, Woodward R, Radjenovic A, Foster JE et al (2015) Assessment of the relationships between myocardial contractility and infarct tissue revealed by serial magnetic resonance imaging in patients with acute myocardial infarction. Int J Cardiovasc Imaging 31(6):1201–1209
Buffa V, Di Renzi P (2020) CMR in the diagnosis of ischemic heart disease. Radiol Med 125:1114–1123
Jeung MY, Germain P, Croisille P, El GS, Roy C, Gangi A (2012) Myocardial tagging with MR imaging: overview of normal and pathologic findings. Radiographics 32(5):1381–1398
Balasubramanian S, Harrild DM, Kerur B, Marcus E, Del Nido P, Geva T et al (2018) Impact of surgical pulmonary valve replacement on ventricular strain and synchrony in patients with repaired tetralogy of Fallot: A cardiovascular magnetic resonance feature tracking study. J Cardiovasc Magn Reson 20(1):1–11
Luetkens JA, Petry P, Kuetting D, Dabir D, Schmeel FC, Homsi R et al (2018) Left and right ventricular strain in the course of acute myocarditis: a cardiovascular magnetic resonance study. RoFo 190(8):722–732
Charbonnel C, Convers-Domart R, Rigaudeau S, Taksin AL, Baron N, Lambert J et al (2017) Assessment of global longitudinal strain at lowdose anthracycline-based chemotherapy, for the prediction of subsequent cardiotoxicity. Eur Heart J Cardiovasc Imaging 18(4):392–401
Taha K, Mast TP, Cramer MJ, van der Heijden JF, Asselbergs FW, Doevendans PA et al (2020) Evaluation of disease progression in arrhythmogenic cardiomyopathy: the change of echocardiographic deformation characteristics over time. JACC Cardiovasc Imaging Vol. 13:631–634
Swat SA, Cohen D, Shah SJ, Lloyd-Jones DM, Baldridge AS, Freed BH et al (2018) Baseline longitudinal strain predicts recovery of left ventricular ejection fraction in hospitalized patients with nonischemic cardiomyopathy. J Am Heart Assoc 7:20
Hiemstra YL, Tomsic A, van Wijngaarden SE, Palmen M, Klautz RJM, Bax JJ et al (2020) Prognostic value of global longitudinal strain and etiology after surgery for primary mitral regurgitation. JACC Cardiovasc Imaging 13(2P2):577–585
Liguori C, Farina D, Vaccher F, Ferrandino G, Bellini D, Carbone I (2020) Myocarditis: imaging up to date. Radiol Med 125:1124–1134
Palumbo P, Cannizzaro E, Di Cesare A, Bruno F, Schicchi N, Giovagnoni A et al (2020) Cardiac magnetic resonance in arrhythmogenic cardiomyopathies. Radiol Med 125(11):1087–1101
Galea N, Polizzi G, Gatti M, Cundari G, Figuera M, Faletti R (2020) Cardiovascular magnetic resonance (CMR) in restrictive cardiomyopathies. Radiol Med 125(11):1072–1086
Romano S, Judd RM, Kim RJ, Kim HW, Klem I, Heitner JF et al (2018) Feature-tracking global longitudinal strain predicts death in a multicenter population of patients with ischemic and nonischemic dilated cardiomyopathy incremental to ejection fraction and late gadolinium enhancement. JACC Cardiovasc Imaging 11(10):1419–1429
Verdonschot JAJ, Merken JJ, Brunner-La Rocca HP, Hazebroek MR, Eurlings CGMJ, Thijssen E et al (2020) Value of speckle tracking-based deformation analysis in screening relatives of patients with asymptomatic dilated cardiomyopathy. JACC Cardiovasc Imaging 13(22):549–558
Hinojar R, Fernández-Golfín C, González-Gómez A, Rincón LM, Plaza-Martin M, Casas E et al (2017) Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis. Int J Cardiol 249:467–472
Zhao X, Tan RS, Tang HC, Leng S, Zhang JM, Zhong L (2018) Analysis of three-dimensional endocardial and epicardial strains from cardiac magnetic resonance in healthy subjects and patients with hypertrophic cardiomyopathy. Med Biol Eng Comput 56(1):159–172
Wu R, An DA, Shi RY, Chen B, Jiang M, Bacyinski A et al (2018) Myocardial fibrosis evaluated by diffusion-weighted imaging and its relationship to 3D contractile function in patients with hypertrophic cardiomyopathy. J Magn Reson Imaging 48(4):1139–1146
Dahhan A, Mohammad A, Kapoor D, Sharma GK (2011) Hypotension due to dynamic left ventricular outflow tract obstruction: after percutaneous coronary intervention. Texas Hear Inst J 38(6):723–726
Geske JB, Sorajja P, Ommen SR, Nishimura RA (2009) Left ventricular outflow tract gradient variability in hypertrophic cardiomyopathy. Clin Cardiol 32(7):397–402
Fifer MA, Vlahakes GJ (2008) Management of symptoms in hypertrophic cardiomyopathy. Circulation 117(3):429–439
van Assen M, Muscogiuri G, Caruso D, Lee SJ, Laghi A, De Cecco CN (2020) Artificial intelligence in cardiac radiology. Radiol Med 125(11):1186–1199
Bloom MW, Greenberg B, Jaarsma T, Januzzi JL, Lam CSP, Maggioni AP et al (2017) Heart failure with reduced ejection fraction. Nat Rev Dis Prim 3:1–20
Di Cesare E, Carerj S, Palmisano A, Carerj ML, Catapano F, Vignale D et al (2021) Multimodality imaging in chronic heart failure. Radiol Med 126:231–242
Geyer H, Caracciolo G, Abe H, Wilansky S, Carerj S, Gentile F et al (2010) Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr 23(4):351–369
Voigt JU, Cvijic M (2019) 2- and 3-dimensional myocardial strain in cardiac health and disease. JACC Cardiovasc Imaging 12(9):1849–1863
Holmes AA, Romero J, Levsky JM, Haramati LB, Phuong N, Rezai-Gharai L et al (2017) Circumferential strain acquired by CMR early after acute myocardial infarction adds incremental predictive value to late gadolinium enhancement imaging to predict late myocardial remodeling and subsequent risk of sudden cardiac death. J Interv Card Electrophysiol 50(3):211–218
Tower-Rader A, Mohananey D, To A, Lever HM, Popovic ZB, Desai MY (2019) Prognostic value of global longitudinal strain in hypertrophic cardiomyopathy: a systematic review of existing literature. JACC Cardiovasc Imaging 12(10):1930–1942
Perry R, Patil S, Marx C, Horsfall M, Chew DP, Sree Raman K et al (2020) Advanced echocardiographic imaging for prediction of SCD in moderate and severe LV systolic function. JACC Cardiovasc Imaging 13(22):604–612
Author information
Authors and Affiliations
Contributions
All authors made a substantial contribution to the information contained in the submitted paper and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Nothing to disclose.
Ethics approval
The study complies with the Declaration of Helsinki principles, and the institutional review board has granted its ethics approval.
Data availability
Data are available on request.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Palumbo, P., Masedu, F., De Cataldo, C. et al. Real-world clinical validity of cardiac magnetic resonance tissue tracking in primitive hypertrophic cardiomyopathy. Radiol med 126, 1532–1543 (2021). https://doi.org/10.1007/s11547-021-01432-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11547-021-01432-x